Prostate-specific Antigen (psa) For Management Of Prostate Cancers

Device Code: 3039

Product Code(s): LTJ

Device Classification Information

Device Type ID3039
Device NameProstate-specific Antigen (psa) For Management Of Prostate Cancers
Regulation DescriptionTumor-associated Antigen Immunological Test System.
Regulation Medical SpecialtyImmunology
Review PanelImmunology
Premarket Review Office Of In Vitro Diagnostics And Radiological Health (OIR)
Submission Type510(k)
CFR Regulation Number866.6010 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodeLTJ
GMP ExemptNo
Summary MREligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Not Third Party Eligible

Recognized Standards

Total Product Life Cycle

Device Type ID3039
DeviceProstate-specific Antigen (psa) For Management Of Prostate Cancers
Product CodeLTJ
FDA Device ClassificationClass 2 Medical Device
Regulation DescriptionTumor-associated Antigen Immunological Test System.
CFR Regulation Number866.6010 [🔎]
Premarket Reviews
ManufacturerDecision
NANOENTEK INC
 
SUBSTANTIALLY EQUIVALENT
1
Device Problems
Low Test Results
43
High Test Results
31
Mechanical Problem
11
Incorrect Or Inadequate Test Results
7
Adverse Event Without Identified Device Or Use Problem
4
Incorrect, Inadequate Or Imprecise Result Or Readings
3
Probe
2
Mixer
2
Incorrect Measurement
1
Seal
1
Device Subassembly
1
Brush
1
Human Factors Issue
1
Total Device Problems 108
Recalls
Manufacturer Recall Class Date Posted
1
Siemens Healthcare Diagnostics, Inc
II Sep-07-2016
2
Tosoh Bioscience Inc
II Jun-05-2018
TPLC Last Update: 2019-04-02 20:22:57

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.